Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Orthofix Medical Narrows FY2025 Sales Guidance from $808.000M-$816.000M to $810.000M-$814.000M vs $813.559M Est

Author: Benzinga Newsdesk | November 04, 2025 07:05am
Orthofix Medical (NASDAQ:OFIX) narrows FY2025 sales outlook from $808.000 million-$816.000 million to $810.000 million-$814.000 million vs $813.559 million estimate.

Posted In: OFIX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist